Biotechnology News

Mon, 2014-06-16 11:01

NORTHWOOD, Ohio--(BUSINESS WIRE)--NAMSA, a global medical device research organization, is working with the Philadelphia Pediatric Medical Device Consortium to address the shortage of medical devices designed for children.

Mon, 2014-06-16 11:01

LEXINGTON, Mass.--(BUSINESS WIRE)--Alzheon to Participate in Global Dementia Legacy Meeting to Increase Investment in Dementia

Mon, 2014-06-16 11:01

SANTA CLARA, Calif. & NORWALK, Conn.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) and Cerno Bioscience today announced that Agilent will distribute Cerno Bioscience’s MassWorks calibration and analysis software with all Agilent GC/...

Mon, 2014-06-16 11:01

CAMBRIDGE, Mass.--(BUSINESS WIRE)--PatientsLikeMe has unveiled a suite of services for pharmaceutical companies that allows them to collaborate with patients on the design of clinical trials and other research.

Mon, 2014-06-16 11:01

BALTIMORE--(BUSINESS WIRE)--Scientists at the forefront of proteomics research can achieve exceptional accuracy and speed using an expanded family of affinity-based consumables for large molecule bioanalysis. The new functionalized pipette tips...

Mon, 2014-06-16 11:01

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company Enters into Agreement With Stanford University for New Drug Delivery Technology

Mon, 2014-06-16 11:01

SAN CARLOS, Calif. & MANHASSET, N.Y.--(BUSINESS WIRE)--Natera, Inc., a leader in non-invasive genetic testing, and the Feinstein Institute for Medical Research today announced that they have entered into a research agreement to analyze cell-...

Mon, 2014-06-16 11:01

LINCOLN, Neb.--(BUSINESS WIRE)--Celerion is pleased to announce the appointment of Robert Lester MD FACC, as Chief Cardiologist, Global Medical Director of Cardiac Safety Services.

Mon, 2014-06-16 11:01

RAMSEY, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (OTCQB: ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious...

Mon, 2014-06-16 11:01

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced data from a Phase 1 clinical trial with LGD-6972 that demonstrate favorable safety, tolerability and pharmacokinetics in normal healthy volunteers and in...

Mon, 2014-06-16 11:01

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced the 7010 Triple Quadrupole GC/MS System featuring a totally redesigned ion source that is a radical departure from the conventional ion sources currently...

Mon, 2014-06-16 11:01

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced a new flagship triple quadrupole mass spectrometer for LC/MS applications requiring the highest sensitivity and robustness. The Agilent 6495 LC/MS Triple...

Mon, 2014-06-16 11:01

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today the opening of a new 280,000 square-foot Research and Development (R&D) hub in Cambridge, Mass. The new Pfizer facilities in Kendall Square bring together 1,000 colleagues from...

Mon, 2014-06-16 11:01

TARRYTOWN, N.Y.--(BUSINESS WIRE)--PsychoGenics Inc. announced today that it has received a license to use the Cntnap2 knockout mouse from Yeda R&D Co. Ltd., the technology transfer company of the Weizmann Institute of Science. The CNTNAP2...

Mon, 2014-06-16 11:01

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research is set to join he Russell 3000 index when Russell Investments reconstitutes the its U.S. and global indexes on June 27

Mon, 2014-06-16 11:01

CAMBRIDGE, Mass. & NORTH CHICAGO, Ill.--(BUSINESS WIRE)--Biogen Idec and AbbVie Announce Positive Top-Line Results from Phase 3 Study of Daclizumab High-Yield Process in Multiple Sclerosis

Mon, 2014-06-16 11:01

BAAR, Switzerland--(BUSINESS WIRE)--Medela launches Thopaz+. Thopaz+ digital chest drainage system provides comprehensive post-operative management of chest tubes for improved patient care and shorter hospital stays.

Mon, 2014-06-16 11:01

FRAMINGHAM, Mass.--(BUSINESS WIRE)--AB SCIEX today introduced TripleTOF 6600 system with SWATH and BioPharmaView as the latest additions to a growing line of solutions to accelerate the study of intact proteins and peptide mapping.

Mon, 2014-06-16 11:01

FRAMINGHAM, Mass.--(BUSINESS WIRE)--AB SCIEX today introduced the TripleTOF® 6600 system with SWATH™ Acquisition 2.0 – the company’s revolutionary solution for quantitative proteomics.

Mon, 2014-06-16 11:01

SAN DIEGO--(BUSINESS WIRE)--Today, at the Drug Information Association’s 50th Annual Meeting, Veeva Systems released the results of the Veeva 2014 Paperless TMF Survey: An Industry Benchmark, the largest TMF survey to date.

Mon, 2014-06-16 11:01

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex to present at World Congress on Vascular Assess 2014 ("WoCoVA") in Berlin

Mon, 2014-06-16 11:01

BILLERICA, Mass. & PISCATAWAY, N.J.--(BUSINESS WIRE)--RUCDR Infinite Biologics®, the largest university biobank, is now a RainDance Technologies Center of Excellence making it a premier reference site and service provider for RainDance...

Mon, 2014-06-16 11:01

NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced that...

Mon, 2014-06-16 11:01

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus, Inc. (NASDAQ:AGEN), an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs), heat shock protein vaccines and adjuvants, announced that it has been selected for inclusion in the...

Mon, 2014-06-16 11:01

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Discloses Experimental Results for Novel Checkpoint Candidate for Cancer Immunotherapy and Discovery of Two New Candidates

Mon, 2014-06-16 11:01

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (NYSE mkt symbol NNVC) is in the preliminary list for addition to the Russell Global, 2000, 3000, and Microcap indexes as per Russell's June 13, 2014 update.

Mon, 2014-06-16 11:01

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today reiterated the Company’s concern regarding Valeant Pharmaceuticals International, Inc.’s (“Valeant”) unsustainable business model, which relies on...

Mon, 2014-06-16 11:01

WALTHAM, MA--(BUSINESS WIRE)--ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, disclosed for the first time preclinical data for IMGN779. The...

Mon, 2014-06-16 07:01

BILLERICA, Mass. & TALLAHASSEE, Fla.--(BUSINESS WIRE)--Bruker Corporation (NASDAQ:BRKR) and the National High Magnetic Field Laboratory (NHMFL) at Florida State University (FSU) today announced the successful installation of the world’s first...

Mon, 2014-06-16 07:01

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology Announces First Patient Enrolled in RUCAPANC Study

Mon, 2014-06-16 07:01

BALTIMORE--(BUSINESS WIRE)--At the 62nd ASMS Conference on Mass Spectrometry and Allied Topics today, Bruker Corporation (NASDAQ:BRKR) today announced mass spectrometry-based product introductions for life-science research and proteomics, for...

Mon, 2014-06-16 07:01

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (NYSE MKT: XXII) announced that the Company will join the Russell 3000, Russell 2000, Russell Global and Russell Microcap Indexes

Mon, 2014-06-16 06:03

PARIS & CAMBRIDGE, England--(BUSINESS WIRE)--Novacyt (NYSE-ALTERNEXT: ALNOV), a leading diagnostics manufacturer that develops and markets innovative solutions in liquid-based cytology for the detection of cancer, including cervical cancer...

Sun, 2014-06-15 21:00

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced topline results from a Phase 3 clinical trial (GS-US-337-0113) in Japan evaluating the investigational once-daily fixed-dose combination of the NS5A...

Sun, 2014-06-15 20:00

HOLLISTON, Mass.--(BUSINESS WIRE)--Veristat and Karyopharm Therapeutics Inc. are entering into a Preferred Provider Agreement for an oncology and novel therapeutic advancement. Veristat providing strategic guidance on study design.

Sun, 2014-06-15 07:01

INGELHEIM, Germany & INDIANAPOLIS, US--(BUSINESS WIRE)--Non-US and Non-UK The first insights from IntroDia™ presented at the American Diabetes Association's (ADA) 74th Scientific Sessions®, showed that over three quarters (76-100 percent...

Sat, 2014-06-14 15:01

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG) today announced that a retrospective analysis of MM-003, the Company’s phase III study of pomalidomide plus low-dose...

Sat, 2014-06-14 15:01

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today released initial positive clinical data...

Sat, 2014-06-14 10:01

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG) today announced that results from AML-001, its phase III study of VIDAZA® (azacitidine for injection) compared to...

Sat, 2014-06-14 05:02

SUMMIT, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) and Acceleron Pharma Inc. (NASDAQ:XLRN) today announced interim data from two studies of candidates from the companies’ joint development program in beta-...

Fri, 2014-06-13 22:01

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ:ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today reaffirmed its belief that it has broad access to intellectual property required to develop...